IN2013MU03610A - - Google Patents
Info
- Publication number
- IN2013MU03610A IN2013MU03610A IN3610MU2013A IN2013MU03610A IN 2013MU03610 A IN2013MU03610 A IN 2013MU03610A IN 3610MU2013 A IN3610MU2013 A IN 3610MU2013A IN 2013MU03610 A IN2013MU03610 A IN 2013MU03610A
- Authority
- IN
- India
- Prior art keywords
- dasatinib monohydrate
- abstract
- commercially
- describes
- preparation
- Prior art date
Links
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical class C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3610MU2013 IN2013MU03610A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2013-12-18 | 2014-12-17 | |
| PCT/IN2014/000782 WO2015107545A1 (en) | 2013-12-18 | 2014-12-17 | Water soluble salts of dasatinib hydrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3610MU2013 IN2013MU03610A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2013-12-18 | 2014-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03610A true IN2013MU03610A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2015-04-24 |
Family
ID=53039939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3610MU2013 IN2013MU03610A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2013-12-18 | 2014-12-17 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03610A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) |
| WO (1) | WO2015107545A1 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019209908A1 (en) | 2018-04-25 | 2019-10-31 | Johnson Matthey Public Limited Company | Crystalline forms of dasatinib |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0009721A (pt) | 1999-04-15 | 2002-02-13 | Bristol Myers Squibb Co | Inibidores de tirosina quinase de proteìna cìclica |
| TWI338004B (en) | 2004-02-06 | 2011-03-01 | Bristol Myers Squibb Co | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| US20050215795A1 (en) | 2004-02-06 | 2005-09-29 | Bang-Chi Chen | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| DK1885339T3 (en) | 2005-05-05 | 2015-10-19 | Bristol Myers Squibb Holdings Ireland | FORMULATIONS OF A SRC / ABL INHIBITOR |
| EP1909795B1 (en) | 2005-06-09 | 2011-04-13 | Bristol-Myers Squibb Company | Pharmaceutical composition for use in treating individuals exhibiting mutant kit protein |
| US20070105867A1 (en) | 2005-09-21 | 2007-05-10 | Bristol-Myers Squibb Company | Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof |
| US20070093499A1 (en) | 2005-10-20 | 2007-04-26 | Bristol-Myers Squibb Company | Use of dasatinib for the treatment of bone metastasis |
| WO2010139979A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
| US9145406B2 (en) * | 2012-04-20 | 2015-09-29 | Shilpa Medicare Limited | Process for preparing dasatinib monohydrate |
-
2014
- 2014-12-17 IN IN3610MU2013 patent/IN2013MU03610A/en unknown
- 2014-12-17 WO PCT/IN2014/000782 patent/WO2015107545A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015107545A1 (en) | 2015-07-23 |